COVID-19 Vaccine update: learn about the clinical efficacy and safety data for a new recombinant protein subunit COVID-19 vaccine approved and available in >35 countries. The video can be viewed at your convenience.
NUVAXOVIDᵀᴹ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) For Individuals 12 Years and Older
We are sorry that this content was not interesting for you!
Let us improve this content!
Tell us how we can improve this content?
Keep your finger on the pulseJoin Now
Elevating the Quality of Healthcare Globally